GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dai Han Pharmaceutical Co Ltd (XKRX:023910) » Definitions » ROE % Adjusted to Book Value

Dai Han Pharmaceutical Co (XKRX:023910) ROE % Adjusted to Book Value : 20.05% (As of Mar. 2024)


View and export this data going back to 1996. Start your Free Trial

What is Dai Han Pharmaceutical Co ROE % Adjusted to Book Value?

Dai Han Pharmaceutical Co's ROE % for the quarter that ended in Mar. 2024 was 13.23%. Dai Han Pharmaceutical Co's PB Ratio for the quarter that ended in Mar. 2024 was 0.66. Dai Han Pharmaceutical Co's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was 20.05%.


Dai Han Pharmaceutical Co ROE % Adjusted to Book Value Historical Data

The historical data trend for Dai Han Pharmaceutical Co's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dai Han Pharmaceutical Co ROE % Adjusted to Book Value Chart

Dai Han Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.09 9.15 13.87 14.58 18.20

Dai Han Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.65 18.36 19.52 14.52 20.05

Competitive Comparison of Dai Han Pharmaceutical Co's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Dai Han Pharmaceutical Co's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dai Han Pharmaceutical Co's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dai Han Pharmaceutical Co's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Dai Han Pharmaceutical Co's ROE % Adjusted to Book Value falls into.



Dai Han Pharmaceutical Co ROE % Adjusted to Book Value Calculation

Dai Han Pharmaceutical Co's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=12.01% / 0.66
=18.20%

Dai Han Pharmaceutical Co's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=13.23% / 0.66
=20.05%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dai Han Pharmaceutical Co ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Dai Han Pharmaceutical Co's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Dai Han Pharmaceutical Co (XKRX:023910) Business Description

Traded in Other Exchanges
N/A
Address
8-3, 4-Ga Yangpyeong-dong, Yeongdeungpo-gu, Seoul, KOR
Dai Han Pharmaceutical Co Ltd is a South Korea based company engages in the manufacture, supply, and distribution of pharmaceutical products such as infusions, injections, drugs used in contrast media, drugs used for external uses and quasi-drugs.

Dai Han Pharmaceutical Co (XKRX:023910) Headlines

No Headlines